Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terry J Fry

Showing results (91-100 of 124) with videos related to

Pageof 13
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2021
Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALLNirali N Shah, Daniel W Lee, Bonnie Yates, et al.
Blood Advances|October 7, 2021
Infectious complications of CAR T-cell therapy across novel antigen targets in the first 30 daysLekha Mikkilineni, Bonnie Yates, Seth M Steinberg, et al.
Pediatric Blood & Cancer|September 22, 2020
Fatal capillary leak syndrome in a child with acute lymphoblastic leukemia treated with moxetumomab pasudotox for pre-transplant minimal residual disease reductionNirali N Shah, Jennifer Schneiderman, Denison Kuruvilla, et al.
Transplantation and Cellular Therapy|July 2, 2023
Chimeric Antigen Receptor T Cells as Salvage Therapy for Post-Chimeric Antigen Receptor T Cell FailureElizabeth M Holland, Bonnie Yates, Seth M Steinberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 22, 2019
Modulation of Target Antigen Density Improves CAR T-cell Functionality and PersistenceSneha Ramakrishna, Steven L Highfill, Zachary Walsh, et al.
Nature Medicine|May 5, 2015
4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptorsAdrienne H Long, Waleed M Haso, Jack F Shern, et al.
Journal for Immunotherapy of Cancer|May 9, 2022
Efficacy of second CAR-T (CART2) infusion limited by poor CART expansion and antigen modulationElizabeth M Holland, John C Molina, Kniya Dede, et al.
Pediatric Blood & Cancer|January 26, 2020
Disease detection methodologies in relapsed B-cell acute lymphoblastic leukemia: Opportunities for improvementHaneen Shalabi, Constance M Yuan, Amita Kulshreshtha, et al.
Blood|October 6, 2022
Murine allogeneic CAR T cells integrated before or early after posttransplant cyclophosphamide exert antitumor effectsMichael T Patterson, Shanzay M Khan, Natalia S Nunes, et al.
Nature Communications|April 10, 2023
Hypoimmune anti-CD19 chimeric antigen receptor T cells provide lasting tumor control in fully immunocompetent allogeneic humanized miceXiaomeng Hu, Karl Manner, Rowena DeJesus, et al.
Pageof 13

Showing results (91-100 of 124) with videos related to

Sort By:
Pageof 13
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2021
Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALLNirali N Shah, Daniel W Lee, Bonnie Yates, et al.
Blood Advances|October 7, 2021
Infectious complications of CAR T-cell therapy across novel antigen targets in the first 30 daysLekha Mikkilineni, Bonnie Yates, Seth M Steinberg, et al.
Pediatric Blood & Cancer|September 22, 2020
Fatal capillary leak syndrome in a child with acute lymphoblastic leukemia treated with moxetumomab pasudotox for pre-transplant minimal residual disease reductionNirali N Shah, Jennifer Schneiderman, Denison Kuruvilla, et al.
Transplantation and Cellular Therapy|July 2, 2023
Chimeric Antigen Receptor T Cells as Salvage Therapy for Post-Chimeric Antigen Receptor T Cell FailureElizabeth M Holland, Bonnie Yates, Seth M Steinberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 22, 2019
Modulation of Target Antigen Density Improves CAR T-cell Functionality and PersistenceSneha Ramakrishna, Steven L Highfill, Zachary Walsh, et al.
Nature Medicine|May 5, 2015
4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptorsAdrienne H Long, Waleed M Haso, Jack F Shern, et al.
Journal for Immunotherapy of Cancer|May 9, 2022
Efficacy of second CAR-T (CART2) infusion limited by poor CART expansion and antigen modulationElizabeth M Holland, John C Molina, Kniya Dede, et al.
Pediatric Blood & Cancer|January 26, 2020
Disease detection methodologies in relapsed B-cell acute lymphoblastic leukemia: Opportunities for improvementHaneen Shalabi, Constance M Yuan, Amita Kulshreshtha, et al.
Blood|October 6, 2022
Murine allogeneic CAR T cells integrated before or early after posttransplant cyclophosphamide exert antitumor effectsMichael T Patterson, Shanzay M Khan, Natalia S Nunes, et al.
Nature Communications|April 10, 2023
Hypoimmune anti-CD19 chimeric antigen receptor T cells provide lasting tumor control in fully immunocompetent allogeneic humanized miceXiaomeng Hu, Karl Manner, Rowena DeJesus, et al.
Pageof 13